GAIL BEAVER: Open Payments
NPI 1689665887 · SAN ANTONIO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$365 in 18 payments from 12 companies in 2025. Trend: 2023 $545 · 2024 $596 · 2025 $365
Food & beverage: $365
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 3 | $63 |
| Amgen Inc. | 3 | $49 |
| AstraZeneca Pharmaceuticals LP | 2 | $42 |
| Lilly USA, LLC | 2 | $37 |
| Lundbeck LLC | 1 | $30 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $25 |
| Abbott Laboratories | 1 | $24 |
| Novartis Pharmaceuticals Corporation | 1 | $24 |
| PFIZER INC. | 1 | $22 |
| Azurity Pharmaceuticals, Inc. | 1 | $21 |
Products named: AIRSUPRA, VRAYLAR, VYEPTI, REPATHA, Kerendia, UBRELVY, FREESTYLE LIBRE 3, LEQVIO.
Industry payments across TX — which companies pay providers there.
